查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1629237

脂多醣免疫分析市场，按类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Lipopolysaccharides Immunoassay Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，脂多醣免疫分析市场规模为19.9409亿美元，2024年至2032年复合年增长率为4.30%。

脂多醣免疫分析市场-市场动态

药品和生物製剂中内毒素检测需求的不断增长以及传染病的流行预计将推动市场需求

对生物製药（特别是生物製品和疫苗）不断增长的需求推动了对有效内毒素检测的需求，以确保这些产品的安全和质量，从而促进市场成长。脂多醣是一种强效内毒素，可引起人类严重的免疫反应，如发烧、感染性休克和器官衰竭。因此，包括 FDA 和 EMA 在内的监管机构要求对注射药物、医疗器材和疫苗进行严格的内毒素检测，以满足安全标准。这增加了这些产品的品质控制和验证过程中对 LPS 免疫测定的需求。政府法规和国际标准在塑造 LPS 免疫分析市场方面发挥着至关重要的作用。包括美国食品药物管理局 (FDA)、欧洲药品管理局 (EMA) 和世界卫生组织 (WHO) 在内的多个卫生当局都制定了严格的内毒素检测指南，以确保产品安全。

包括细菌感染在内的传染病的增加以及最近爆发的 COVID-19 等流行病，凸显了快速、准确的内毒素检测的重要性。脂多醣存在于革兰氏阴性菌的外膜中，与免疫系统活化和发炎反应有关。因此，有效的 LPS 免疫测定对于诊断细菌感染和监测发炎性疾病至关重要。此类疾病发病率的不断上升推动了对灵敏、快速检测方法的需求，以监测和管理疫情。此外，持续关注免疫学、传染病和内毒素检测技术的研发（R＆D）也有助于市场的成长。

脂多醣免疫分析市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 4.30% 左右的复合年增长率成长

根据类型细分，由于传染病药物和开发以及疫苗的需求不断增加，预计试剂盒和试剂细分市场将在 2023 年显示最大的市场份额。

根据应用细分，由于新药和新发现的不断增加，研发领域成为 2023 年的领先应用。

根据最终用户细分，由于医院设施对套件和仪器的需求很高，医院细分市场将在 2023 年成为领先的最终用户细分市场。

按地区划分，由于对医院基础设施的投资，北美将成为 2023 年的主要收入来源。

脂多醣免疫分析市场-細項分析：

全球脂多醣免疫分析市场根据类型、应用、最终用户和地区进行细分。

市场依类型分为三类：试剂盒和试剂、仪器和消耗品。试剂盒和试剂细分市场占据主导地位。药品需求的成长和免疫分​​析技术的进步预计将推动该领域的成长。

市场依应用分为三类：临床试验、研发等。由于免疫学内毒素检测技术的投资不断增加，补充了市场的成长，预计研发领域将在预测期内占据主导地位。

根据最终用户，市场分为三类：医院、诊所和其他。医院领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。医院越来越多地采用先进的免疫分析方法，推动了细分市场的需求。

脂多醣免疫分析市场-地理洞察

在全球范围内，脂多醣免疫分析市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。北美在 LPS 免疫分析市场占据主导地位，主要是由于其完善的医疗保健系统、广泛的製药和生物技术行业以及严格的监管标准。美国在该地区占有最大份额，在品质控制中大量采用免疫测定法。由于其强劲的製药业以及遵守严格的欧盟药品和设备安全法规，欧洲占第二大市场份额。欧洲药品管理局 (EMA) 执行严格的内毒素检测标准，推动了市场的发展。在医疗基础设施投资增加以及生物製品和疫苗需求不断增长的推动下，亚太地区预计将出现最快的成长。

脂多醣免疫分析市场-竞争格局：

在诊断技术的进步以及临床和研究应用需求不断增长的推动下，脂多醣免疫分析市场正在经历显着的竞争动态。市场主要参与者，如 BioChek (BIOTECON Diagnostics)、AdVnt Biotechnologies、Thermo Fisher Scientific 等。例如，即时检测解决方案因其在诊断心血管等疾病方面的应用而受到关注。多家公司正在与研究机构和医疗保健提供者合作，以提高检测的特异性和准确性。

最新进展：

2023 年，赛默飞世尔科技推出了先进的免疫测定试剂盒，提高了 LPS 检测的敏感度。

2023 年，Response Biomedical 在研发方面投入了大量资金，以提高用于快速床边诊断的侧流免疫分析 (LFA) 的性能。

目录

第 1 章：脂多醣免疫分析市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按类型分類的脂多醣免疫分析市场片段
    • 脂多醣免疫分析市场片段（依应用）
    • 最终用户的脂多醣免疫分析市场片段
    • 按国家/地区分類的脂多醣免疫分析市场片段
    • 按地区分類的脂多醣免疫分析市场片段
  • 竞争洞察

第 3 章：脂多醣免疫分析主要市场趋势

  • 脂多醣免疫分析市场驱动因素
    • 市场驱动因素的影响分析
  • 脂多醣免疫分析市场限制
    • 市场限制影响分析
  • 脂多醣免疫分析市场机会
  • 脂多醣免疫分析市场未来趋势

第 4 章：脂多醣免疫分析产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：脂多醣免疫分析市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：脂多醣免疫测定市场格局

  • 脂多醣免疫分析市占率分析，2024 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：脂多醣免疫分析市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 试剂盒和试剂
    • 仪器仪表
    • 耗材

第 8 章：脂多醣免疫分析市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 临床试验
    • 研究与开发
    • 其他的

第 9 章：脂多醣免疫分析市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 医院
    • 诊所
    • 其他的

第 10 章：脂多醣免疫分析市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美脂多醣免疫分析主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲脂多醣免疫分析主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区脂多醣免疫分析主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲脂多醣免疫分析主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲脂多醣免疫分析主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析-脂多醣免疫分析产业

  • 竞争仪表板
  • 公司简介
    • Thermo Fisher Scientific
    • Bio-Techne
    • BioChek (BIOTECON Diagnostics)
    • AdVnt Biotechnologies
    • Response Biomedical
    • New Horizons Diagnostic Corporation
    • Merck KGaA
    • Lonza Group AG
    • Abcam plc
    • Creative Diagnostics
    • GenScript Biotech Corporation
    • Enzo Life Sciences
    • MyBioSource, Inc.
    • PerkinElmer, Inc.
    • R&D Systems
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4369

REPORT HIGHLIGHT

Lipopolysaccharides Immunoassay Market size was valued at USD 1,994.09 Million in 2023, expanding at a CAGR of 4.30% from 2024 to 2032.

A Lipopolysaccharides (LPS) Immunoassay is a laboratory technique used to detect and quantify lipopolysaccharides, which are large molecules found in the outer membrane of Gram-negative bacteria. LPS are significant because they play a key role in triggering the immune response in humans and animals and are often considered endotoxins.

Lipopolysaccharides Immunoassay Market- Market Dynamics

Rising demand for endotoxin testing in pharmaceuticals and biologics and prevalence of infectious diseases are expected to propel market demand

The growing demand for biopharmaceuticals, particularly biologics and vaccines, has driven the need for effective endotoxin testing to ensure the safety and quality of these products, boosting market growth. Lipopolysaccharides are potent endotoxins that can induce severe immune responses in humans, such as fever, septic shock, and organ failure. Consequently, regulatory bodies, including the FDA and EMA, require rigorous endotoxin testing of injectable drugs, medical devices, and vaccines to meet safety standards. This has bolstered the demand for LPS immunoassays in the quality control and validation processes of these products. Government regulations and international standards play a critical role in shaping the LPS immunoassay market. Various health authorities, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO), have stringent guidelines for endotoxin testing to ensure product safety.

The increase in infectious diseases, including bacterial infections and the recent epidemic outbreaks such as COVID-19, has highlighted the importance of rapid and accurate endotoxin detection. Lipopolysaccharides, found in the outer membrane of Gram-negative bacteria, are linked to immune system activation and inflammatory responses. As a result, effective LPS immunoassays are crucial for diagnosing bacterial infections and monitoring inflammatory diseases. The growing incidence of such diseases drives the demand for sensitive and rapid detection methods to monitor and manage outbreaks. Also, a continuous focus on research and development (R&D) in immunology, infectious diseases, and endotoxin detection technologies contributes to the market's growth.

Lipopolysaccharides Immunoassay Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.30% over the forecast period (2024-2032)

Based on Type segmentation, kits & reagents segment was predicted to show maximum market share in the year 2023, owing to increasing demand from drugs & developments and vaccines for infectious diseases.

Based on Application segmentation, research & developments segment was the leading application in 2023, due to rising novel drugs & discoveries.

Based on End User segmentation, hospital segment was the leading End User segment in 2023, due to high demand for kits and instruments in hospital facilities.

On the basis of region, North America was the leading revenue generator in 2023, owing to investments in hospital infrastructure.

Lipopolysaccharides Immunoassay Market- Segmentation Analysis:

The Global Lipopolysaccharides Immunoassay Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into three categories based on Type: kits & reagents, instruments, and consumables. The kits & reagents segment dominates the market. The growing demand from pharmaceuticals and advancement in immunoassay technologies is expected to boost segment growth.

The market is divided into three categories based on the Application: clinical trials, research & development, and others. The research & development segment is expected to dominate over the forecast period, owing to the rising investment in immunology endotoxin detection technologies supplementing market growth.

The market is divided into three categories based on End User: hospital, clinics, and others. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. The increasing adoption of advanced immunoassay methods at hospitals is boosting segment demand.

Lipopolysaccharides Immunoassay Market- Geographical Insights

Worldwide, the Lipopolysaccharides Immunoassay market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the LPS immunoassay market, primarily due to its well-established healthcare system, extensive pharmaceutical and biotechnology industries, and stringent regulatory standards. The U.S. contributes the largest share in this region, with significant adoption of immunoassays in quality control. Europe holds the second-largest market share due to its robust pharmaceutical sector and adherence to stringent EU regulations for drug and device safety. The European Medicines Agency (EMA) enforces rigorous standards for endotoxin testing, propelling the market. The Asia-Pacific region is expected to witness the fastest growth, driven by increasing investment in healthcare infrastructure and rising demand for biologics and vaccines.

Lipopolysaccharides Immunoassay Market- Competitive Landscape:

The Lipopolysaccharides Immunoassay market is experiencing significant competitive dynamics, driven by advancements in diagnostic technologies and increasing demand across clinical and research applications. Key players in the market, such as BioChek (BIOTECON Diagnostics), AdVnt Biotechnologies, Thermo Fisher Scientific, etc. Several companies have launched or enhanced their offerings, focusing on rapid diagnostic kits and advanced immunoassay technologies such as ELISA and CLIA. For instance, point-of-care testing solutions are gaining traction due to their application in diagnosing diseases like cardiovascular. Several firms are partnering with research institutions and healthcare providers to enhance assay specificity and accuracy.

Recent Developments:

In 2023, Thermo Fisher Scientific has introduced advanced immunoassay kits with enhanced sensitivity for LPS detection.

In 2023, Response Biomedical invested a significant share in R&D to improve the performance of lateral flow immunoassays (LFAs) for rapid bedside diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET KEY PLAYERS

  • Thermo Fisher Scientific
  • Bio-Techne
  • BioChek (BIOTECON Diagnostics)
  • AdVnt Biotechnologies
  • Response Biomedical
  • New Horizons Diagnostic Corporation
  • Merck KGaA
  • Lonza Group AG
  • Abcam plc
  • Creative Diagnostics
  • GenScript Biotech Corporation
  • Enzo Life Sciences
  • MyBioSource, Inc.
  • PerkinElmer, Inc.
  • R&D Systems
  • Others

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Kits & reagents
  • Instruments
  • Consumables

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Clinical Trials
  • Research & Development
  • Others

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital
  • Clinics
  • Others

GLOBAL LIPOPOLYSACCHARIDES IMMUNOASSAY MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Lipopolysaccharides Immunoassay Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lipopolysaccharides Immunoassay Market Snippet by Type
    • 2.1.2. Lipopolysaccharides Immunoassay Market Snippet by Application
    • 2.1.3. Lipopolysaccharides Immunoassay Market Snippet by End User
    • 2.1.4. Lipopolysaccharides Immunoassay Market Snippet by Country
    • 2.1.5. Lipopolysaccharides Immunoassay Market Snippet by Region
  • 2.2. Competitive Insights

3. Lipopolysaccharides Immunoassay Key Market Trends

  • 3.1. Lipopolysaccharides Immunoassay Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lipopolysaccharides Immunoassay Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lipopolysaccharides Immunoassay Market Opportunities
  • 3.4. Lipopolysaccharides Immunoassay Market Future Trends

4. Lipopolysaccharides Immunoassay Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lipopolysaccharides Immunoassay Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Lipopolysaccharides Immunoassay Market Landscape

  • 6.1. Lipopolysaccharides Immunoassay Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lipopolysaccharides Immunoassay Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Kits & reagents
    • 7.1.3. Instruments
    • 7.1.4. Consumables

8. Lipopolysaccharides Immunoassay Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Clinical Trials
    • 8.1.3. Research & Development
    • 8.1.4. Others

9. Lipopolysaccharides Immunoassay Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Lipopolysaccharides Immunoassay Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Lipopolysaccharides Immunoassay Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Lipopolysaccharides Immunoassay Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Lipopolysaccharides Immunoassay Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Lipopolysaccharides Immunoassay Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Lipopolysaccharides Immunoassay Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Lipopolysaccharides Immunoassay Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific
    • 11.2.2. Bio-Techne
    • 11.2.3. BioChek (BIOTECON Diagnostics)
    • 11.2.4. AdVnt Biotechnologies
    • 11.2.5. Response Biomedical
    • 11.2.6. New Horizons Diagnostic Corporation
    • 11.2.7. Merck KGaA
    • 11.2.8. Lonza Group AG
    • 11.2.9. Abcam plc
    • 11.2.10. Creative Diagnostics
    • 11.2.11. GenScript Biotech Corporation
    • 11.2.12. Enzo Life Sciences
    • 11.2.13. MyBioSource, Inc.
    • 11.2.14. PerkinElmer, Inc.
    • 11.2.15. R&D Systems
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us